$80,000 of ABBVIE INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"International tax issues and pharmaceutical pricing and access issues, and patent issues. International tax issues and pharmaceutical pricing and access issues, and patent issues."
You can find more data on corporate lobbying on Quiver Quantitative.
ABBV Congressional Stock Trading
Members of Congress have traded $ABBV stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ABBV stock by members of Congress over the last 6 months:
- REPRESENTATIVE PETE SESSIONS sold up to $50,000 on 09/14.
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 05/05.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
ABBV Insider Trading Activity
ABBV insiders have traded $ABBV stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ABBV stock by insiders over the last 6 months:
- NICHOLAS DONOGHOE (EVP, CHIEF BUS/STRAT OFFICER) sold 32,710 shares for an estimated $8,177,500
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
ABBV Hedge Fund Activity
We have seen 2,076 institutional investors add shares of ABBV stock to their portfolio, and 1,677 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 47,862,796 shares (+inf%) to their portfolio in Q2 2026, for an estimated $12,044,193,985
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 12,914,230 shares (+inf%) to their portfolio in Q2 2026, for an estimated $3,249,736,837
- FRANKLIN RESOURCES INC added 5,373,163 shares (+36.9%) to their portfolio in Q2 2026, for an estimated $1,352,102,737
- DIAMANT ASSET MANAGEMENT, INC. removed 3,654,526 shares (-99.5%) from their portfolio in Q2 2026, for an estimated $919,624,922
- CAPITAL WORLD INVESTORS added 3,337,599 shares (+21.1%) to their portfolio in Q2 2026, for an estimated $839,873,412
- MARSHALL WACE, LLP added 2,989,451 shares (+281757.9%) to their portfolio in Q2 2026, for an estimated $752,265,449
- SG AMERICAS SECURITIES, LLC added 2,849,663 shares (+251.0%) to their portfolio in Q2 2026, for an estimated $717,089,197
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
ABBV Price Targets
Multiple analysts have issued price targets for $ABBV recently. We have seen 7 analysts offer price targets for $ABBV in the last 6 months, with a median target of $273.0.
Here are some recent targets:
- Vamil Divan from Guggenheim set a target price of $261.0 on 07/09/2026
- Chris Schott from JP Morgan set a target price of $280.0 on 07/09/2026
- Carter Gould from Cantor Fitzgerald set a target price of $265.0 on 07/06/2026
- Gary Nachman from Canaccord Genuity set a target price of $273.0 on 06/23/2026
- David Amsellem from Piper Sandler set a target price of $298.0 on 06/23/2026
- Gavin Clark-Gartner from Evercore ISI Group set a target price of $235.0 on 05/15/2026
- Terence Flynn from Morgan Stanley set a target price of $278.0 on 04/30/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
